Back to Search
Start Over
Azura Ophthalmics Provides Update on AZR-MD-001 Phase 2 Clinical Program Targeting Meibomian Gland Dysfunction
- Source :
- Business Wire. September 28, 2022
- Publication Year :
- 2022
-
Abstract
- Receives IND clearance for Phase 2b program in U.S. Topline data from ongoing Phase 2b clinical trial to be reported in Q4 2022 TEL AVIV, Israel & MELBOURNE, Australia -- [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.719946386